Literature DB >> 1403388

Atypical features of the hepatic form of carnitine palmitoyltransferase deficiency in a Hutterite family.

J C Haworth1, F Demaugre, F A Booth, L A Dilling, S P Moroz, S S Seshia, L E Seargeant, P M Coates.   

Abstract

We describe hepatic carnitine palmitoyltransferase (CPT I) deficiency in three children (a brother and sister and their second cousin) from an extended inbred Hutterite kindred. The patients were first seen between 8 and 18 months of age with recurrent episodes of hypoketotic hypoglycemia accompanied by a decreased level of consciousness and hepatomegaly. One patient had two Reye syndrome-like episodes. Abnormal organic acids were rarely detected in urine. Serum total and free carnitine levels were elevated in all three patients. Fibroblast acyl-coenzyme A dehydrogenase activities were normal in all, but palmitic acid oxidation, performed in fibroblasts from one patient, was less than 10% of control values. Activity of CPT I in cultured skin fibroblasts from the three patients was 10% to 15% of control levels; CPT II activity was normal. Activity of CPT I and CPT II in muscle from one patient was normal. Atypical features in two of these patients were greatly elevated levels of liver enzymes and creatine kinase during acute episodes. The patients have recently been successfully treated with medium-chain triglycerides and avoidance of fasting. Early identification and treatment of this disorder may avert potentially fatal episodes of hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1403388     DOI: 10.1016/s0022-3476(05)81143-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  A Novel Mutation in CPT1A Resulting in Hepatic CPT Deficiency.

Authors:  Monique Fontaine; Anne-Frédérique Dessein; Claire Douillard; Dries Dobbelaere; Michèle Brivet; Audrey Boutron; Mokhtar Zater; Karine Mention-Mulliez; Annie Martin-Ponthieu; Christine Vianey-Saban; Gilbert Briand; Nicole Porchet; Joseph Vamecq
Journal:  JIMD Rep       Date:  2012-01-31

2.  Carnitine palmitoyltransferase 1A deficiency: abnormal muscle biopsy findings in a child presenting with Reye's syndrome.

Authors:  M Bellusci; P Quijada-Fraile; D Barrio-Carreras; E Martin-Hernandez; M Garcia-Silva; B Merinero; B Perez; A Hernandez-Lain
Journal:  J Inherit Metab Dis       Date:  2017-05-02       Impact factor: 4.982

3.  Successful long-term treatment of hepatic carnitine palmitoyltransferase I deficiency and a novel mutation.

Authors:  J M Stoler; M A Sabry; C Hanley; C L Hoppel; V E Shih
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

4.  Features of carnitine palmitoyltransferase type I deficiency.

Authors:  S E Olpin; J Allen; J R Bonham; S Clark; P T Clayton; J Calvin; M Downing; K Ives; S Jones; N J Manning; R J Pollitt; S J Standing; M S Tanner
Journal:  J Inherit Metab Dis       Date:  2001-02       Impact factor: 4.982

5.  Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension.

Authors:  Shruti Sharma; Neetu Sud; Dean A Wiseman; A Lee Carter; Sanjiv Kumar; Yali Hou; Thomas Rau; Jason Wilham; Cynthia Harmon; Peter Oishi; Jeffrey R Fineman; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-16       Impact factor: 5.464

Review 6.  Disorders of mitochondrial long-chain fatty acid oxidation.

Authors:  R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

Review 7.  Pathophysiology of fatty acid oxidation disorders and resultant phenotypic variability.

Authors:  Simon E Olpin
Journal:  J Inherit Metab Dis       Date:  2013-05-15       Impact factor: 4.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.